Neoadjuvant chemotherapy less commonly used in breast cancer

Published Date: 02 Mar 2023

Most women will have breast cancer surgery first if the initial consultation is with a surgeon. This study has been published as a preprint and has not yet been peer-reviewed.

Read Full News

Latest News

STS: Society of Thoracic Surgeons

Nobel-Winning Doctor Dies; 'Buffy' Star's Heart Defect; Cyberattack Delays Surgeries

Health news and commentary gathered by MedPage Today staff

Jehovah's Witnesses Transfusion Policy Now Allows Storage, Use of One's Own Blood

"I don't think it goes far enough, but it's a significant change," said one former member

Are We Missing Tumors When Using Antibiotics Alone for Appendicitis?

Study address key concern with nonoperative management of appendicitis

How Secretive Traditional Circumcision Rites Are Responsible for Dozens of Deaths

At least 48 boys and young men died during initiation ceremonies in South Africa

3 Medical Schools Under Investigation; 9 Sick in Outbreak; 5-Second Rule in the OR?

Health news and commentary gathered by MedPage Today staff

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

Health news and commentary gathered by MedPage Today staff

"I don't think it goes far enough, but it's a significant change," said one former member

Study address key concern with nonoperative management of appendicitis

At least 48 boys and young men died during initiation ceremonies in South Africa

Health news and commentary gathered by MedPage Today staff

News All Time

You Haven’t Aged a Day: The Prognostic Value of Facial Aging

An AI study suggests that the rate of facial aging could be a biomarker for cancer mortality.

Intraoperative Irradiation Safe for Breast Cancer Relapse

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients with late local recurrence of breast cancer.

Pancreatic Cancer: Should Surgery or Chemo Come First?

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with operable pancreatic cancer. Here’s what we know.

Surgical Robots: NHS Ambition Outpacing Delivery

RCS England finds no national strategy for funding or distributing surgical robots, leaving some hospitals reliant on local fundraising.

NDAs Are Illegal in Healthcare, Says Ethicist

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

BC Rate Low in BRCA Carriers After Risk-Reducing Mastectomy

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Physalis minima (Golden Cherry)

Also known as golden cherry, Physalis minima is used often to treat inflammation, neurodegenerative disorders, and cancer in East Malaysian traditional medicine.

Should Doctors Strike to Limit AI Use at Work?

Some healthcare workers have been able to limit the role of AI in their work after going on strike. Is this a useful tactic for doctors?

Q&A: When Is It Safe to Skip Surgery for DCIS?

Active surveillance is gaining traction for women with low-risk DCIS, but key questions on patient selection and long-term safety remain.

Surveillance or Surgery for Low-Risk DCIS

Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer follow-up is needed.

Recommended News For You

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

Why breast cancer survivors don't take their medicine, and what can be done about it.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Recommended Articles For You

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia 

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Understanding the Rare Disease: Werner Syndrome Explained  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Radiation therapy can promote amphiregulin, which increases growth of metastases

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

DNA origami offers more accurate imaging in the fight against pancreatic cancer

5.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

1.

Colon Cancer Staging: What You Need to Know

2.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

3.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

4.

Everything You Need to Know About HTLV: A Comprehensive Guide 

5.

Uncovering the Mysteries of the RDW Blood Test

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

4.

Understanding the causes of anemia in adults beyond nutritional deficiencies

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot